[基因工程在严重缺血治疗中的潜力与前景]
[Genetic engineering potential and perspectives in the management of critical ischemia].
作者信息
Konstantinov B A, Bochkov N P, Gavrilenko A V, Voronov D A, Tarantul V Z, Sheremet'eva G F, Skrylev S I, Khaĭdarova N V
机构信息
Department of Vascular Surgery, Russian Research Center of Surgery, Russian Academy of Medical Sciences, Moscow, Russia.
出版信息
Angiol Sosud Khir. 2003;9(3):14-8.
The paper presents a new approach to management of lower limb critical ischemia which implements recent advances in molecular biology and genetic engineering technologies. A new original compound incorporating angiogenin gene was developed to activate neoangiogenesis processes after injection into living tissues. Experimental data evidence a potential efficacy of new method for complex management of critical ischemia.
本文提出了一种下肢严重缺血的新管理方法，该方法应用了分子生物学和基因工程技术的最新进展。开发了一种新的含有血管生成素基因的原创化合物，在注入活体组织后可激活新生血管生成过程。实验数据证明了这种新方法对严重缺血进行综合管理的潜在疗效。
Zotero 插件